LSC Recent Webinars on BIO
-
Human Factors Testing: Engaging End-Users In Med Device Development
3/11/2025
Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights
3/5/2025
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
-
Digital Enhancements For Operational Excellence
2/20/2025
Unlock operational excellence with digital enhancements. Discover practical strategies to reduce errors, streamline processes, and drive continuous improvement across industries.
-
Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective
2/18/2025
Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.
-
Contract Manufacturing: Must-Know Trends And Strategies For 2025
2/12/2025
Regulated industries face rising demand, tech breakthroughs, and regulatory harmonization. Discover how contract manufacturers must leverage AI and cloud solutions to stay agile and compliant in the future.
-
The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies
1/29/2025
Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.
-
Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics
1/22/2025
Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.
-
Growing A Sustainability Culture Across An Expanding CDMO Network
1/15/2025
Peter Skals, Head of Global Sustainability, shares how the company is integrating its climate and ESG strategy while simultaneously expanding its CDMO network and reducing its CO2 footprint.
-
Rapid Process Development And Technical Support For AAV Scaleup
12/17/2024
Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.
-
mAb Up- And Downstream Process Intensification Strategies
12/12/2024
Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.